Anne Rogove Stone

Turbett Surgical is committed to delivering instrument processing solutions to hospitals and surgery centers. our patented Instrument Pod increases throughput and dramatically reduces the OR turnover time. Dedicating an OR room to the Instrument Pod increases that rooms capacity by 12%, allowing an extra surgery per day.

J.P. Morgan is a leader in financial services, offering solutions to clients in more than 100 countries with one of the most comprehensive global product platforms available. We have been helping our clients to do business and manage their wealth for more than 200 years. Our business has been built upon our core principle of putting our clients​ interests first. J.P. Morgan is part of JPMorgan Chase & Co. (NYSE: JPM), a global financial services firm. Social Media Terms and Conditions: https://bit.ly/JPMCSocialTerms © 2017 JPMorgan Chase & Co. JPMorgan Chase is an equal opportunity and affirmative action employer Disability/Veteran.

Naveris® Inc. is a molecular diagnostics company developing and commercializing novel blood and saliva tests to enhance the early detection and clinical management of viral-associated cancers. The company’s NavDx® blood test, which uses proprietary technology to detect tumor tissue modified viral (TTMV®)-HPV DNA, is in use at leading cancer treatment centers and academic medical centers throughout the United States. www.naveris.com www.navdx.com

Turbett Surgical is committed to delivering instrument processing solutions to hospitals and surgery centers. our patented Instrument Pod increases throughput and dramatically reduces the OR turnover time. Dedicating an OR room to the Instrument Pod increases that rooms capacity by 12%, allowing an extra surgery per day.

Biolog has the tools, services, and support to provide the microbial phenotypic characterization and polyphasic identification capabilities required to produce functionally relevant insights. Our products and services enable characterization of microbial and mammalian cells as well as identification of thousands of species of bacteria, yeast, and fungi. Learn more at biolog.com.

J.P. Morgan is a leader in financial services, offering solutions to clients in more than 100 countries with one of the most comprehensive global product platforms available. We have been helping our clients to do business and manage their wealth for more than 200 years. Our business has been built upon our core principle of putting our clients​ interests first. J.P. Morgan is part of JPMorgan Chase & Co. (NYSE: JPM), a global financial services firm. Social Media Terms and Conditions: https://bit.ly/JPMCSocialTerms © 2017 JPMorgan Chase & Co. JPMorgan Chase is an equal opportunity and affirmative action employer Disability/Veteran.

Naveris® Inc. is a molecular diagnostics company developing and commercializing novel blood and saliva tests to enhance the early detection and clinical management of viral-associated cancers. The company’s NavDx® blood test, which uses proprietary technology to detect tumor tissue modified viral (TTMV®)-HPV DNA, is in use at leading cancer treatment centers and academic medical centers throughout the United States. www.naveris.com www.navdx.com

Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision.